Pharma is losing the AI talent war against startups: Analysisnews2025-01-11T14:00:12+00:00January 11th, 2025|Endpoints News|
FDA adcomm votes to support Seikagaku’s herniated disc injectionnews2025-01-10T21:24:46+00:00January 10th, 2025|Endpoints News|
Lawmakers ask administration to tighten China trial rulesnews2025-01-10T20:03:11+00:00January 10th, 2025|Endpoints News|
Pfizer touts bladder cancer results as first advancement for some patients ‘in decades’news2025-01-10T19:17:13+00:00January 10th, 2025|Endpoints News|
Lilly finances new $500M biotech fund managed by a16znews2025-01-10T18:08:49+00:00January 10th, 2025|Endpoints News|
AbbVie writes off $3.5B on Cerevel drug after Phase 2 failuresnews2025-01-10T16:14:26+00:00January 10th, 2025|Endpoints News|
Lilly ventures into pulmonary fibrosis with startup Mediarnews2025-01-10T12:00:05+00:00January 10th, 2025|Endpoints News|
Bayer says elinzanetant quelled hot flashes in women undergoing cancer treatmentnews2025-01-09T19:58:36+00:00January 9th, 2025|Endpoints News|
After lackluster 2024, biopharma industry prays stalled M&A will finally move into gearnews2025-01-09T16:06:46+00:00January 9th, 2025|Endpoints News|
Revance weighs competing buyout offer amid push from original biddernews2025-01-08T20:45:20+00:00January 8th, 2025|Endpoints News|
